David Fooksman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
David Fooksman has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Zachary Benet
Dren Bio, Inc., Foster City, CA, USA
5 shared publicationsZhixin Jing
Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA
5 shared publications- Grégoire Lauvau
Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA
4 shared publications - Luis Ovando
Department of Pathology, Albert Einstein College of Medicine
4 shared publications - Zhixin Jing
Lymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH
4 shared publications - Deyou Zheng
Department of Genetics, Albert Einstein College of Medicine, Bronx, NY, USA
3 shared publications
Latest Publications
- 30 October 2026
- Published by Springer Nature
- p. 139-155
Multiphoton Imaging of the Tibial Bone Marrow for In Vivo Spatial-Temporal Analysis of Myeloma Microenvironment and Treatment
- 30 October 2026
- Published by Springer Nature
- p. 139-155
Multiphoton Imaging of the Tibial Bone Marrow for In Vivo Spatial-Temporal Analysis of Myeloma Microenvironment and Treatment
- Open Access
- 9 July 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1916518
Editorial: Decoding the spectrum of plasma cell heterogeneity: insights into maturity and longevity
A foundational question underlying this collection is how a newly minted, SL ASC in peripheral blood becomes a LLPC in the BM [3; 6; 7]. Two articles address this trajectory directly and a third provides critical ecological context.Koike and Ise offer a conceptual map of the journey, highlighting the anatomical segregation between induction sites, i.e., secondary lymphoid organs (SLO), where ASC are first generated, and effector sites, where LLPC reside. The review summaries recent advances in identifying LLPC precursors among newly generated ASC in SLO and traces the molecular programs governing their subsequent migration and maturation within the BM. Both cell-intrinsic programs and extrinsic niche signals emerge as indispensable: longevity is not an intrinsic property present at ASC birth, but progressively acquired as the cells adapt into supportive microenvironments.That maturation process has a measurable functional correlate. Nguyen et al. report experimental evidence antibody secretion is not static across the ASC lifespan. Using bulk and single-cell cultures in an in vitro BM mimetic survival system, the authors show mature BM ASC produce more IgG per cell than early-minted blood counterparts. Critically, blood ASC cultured in supportive conditions increase secretion rates overtime and acquire LLPC-like phenotypes, establishing functional output is coupled to maturational stage. This work provides a quantitative dimension to the developmental arc described by Koike and Ise, anchoring the PC biology in humans.How much room exists in the BM for this maturation to occur at scale? Tonouchi et al. tackle this question with an elegant pulse-labeling strategy in mice. Their findings demonstrate active gutassociated germinal centers (GC) continuously seed the BM with new PC, with GC-derived PC accumulating to represent ~1/3 BM PC examined at 70-80 days. The findings suggest the BM PC compartment remains dynamic with continuous inputs from ongoing immune responses, appertaining to vaccine durability and competitive niche occupancy.If the developmental arc explains the temporal dimension of PC diversity, the heterogeneity axis captures its depth. Multiple articles examine why PC with similar origins can behave differently (beyond age and location).Reinke et al. provide a molecular account of LLPC survival, focusing on the receptor-signaling networks, particularly TACI and CD28, that support LLPC to engage survival signals and upregulate anti-apoptotic machinery. The review highlights how LLPC differ from SL ASC: by a constellation of cell-intrinsic programs unlocked by the BM microenvironment. While the question of why some PC access this longevity program and others do not remains incompletely answered, this review sharpens the molecular lexicon for pursuing it.Akessé and Bonaud broaden the conceptual frame by cataloguing the multiple axes along which PC diversity is shaped. B cell precursor identity, antigen affinity, BCR signaling strength, Ig isotype, microenvironments, cytokines, cellular interactions, and temporal variables -including age, sex, and inflammatory status -all contribute to PC fate. The authors introduce the concept of "Moment" to capture how these temporal and contextual variables modulate PC differentiation throughout maturation, arguing for a model in which heterogeneity is an adaptive feature of the humoral responses. This framework complements the mechanistic detail in Reinke et al. by offering a higherorder view of the landscape.The methodological foundations for studying PC heterogeneity are addressed by Pioli and Pioli, who survey the contribution of genetically modified mouse models to the field. From early transgenic reporters marking PC identity to modern timestamping approaches allowing tracking of PC origins and lineage trajectories, the review maps the technical infrastructure for biological discoveries. This perspective piece underscores advances in understanding PC heterogeneity have been coupled to the availability of refined mouse models and points forward to where next-generation tools may take the field.PC do not exist in isolation: their survival, identity, and functions are shaped by the tissues they reside [8]. Multiple contributions examine this spatial dimension.The niche perspective offered by Tonouchi et al. is complemented by two reviews that expand its geographical frame. Wang et al. summarize the biology governing the circulating PC (CPC) pool, a small but diagnostically significant fraction of PC persistent in peripheral blood. Beyond a role as proxies for immune activation, CPC are emerging as biomarkers across infections, autoimmune diseases, and PC malignancies, with recent guidelines recognizing elevated CPC as an adverse prognostic feature in multiple myeloma. This article bridges PC biology to liquid biopsy approaches that reshape disease monitoring.Merder and Moseman extend the tissue map further. The authors examine PC that accumulate within the central nervous system (CNS) and its border zones (meninges, olfactory mucosa, and brain parenchyma). Traditionally viewed as sites poorly accessible to humoral immunity, the CNS and its borders are increasingly recognized as locations where PC function in both defense and pathology. The review recaps how local PC differentiation, migration, and persistence in the CNS contribute to neuroinvasive infection responses, CNS-targeting autoimmunity, and tumor immunology. It suggests the parallels with LLPC biology in the BM: specialized niches support local PC persistence across multiple tissues, inquiring whether general principles of niche-driven longevity operate throughout the body.The translational implications of this field run in two directions: exploiting PC biology for vaccine design and understanding its dysregulation in disease. Together, these 10 articles sketch a unified picture of PC biology where heterogeneity serves as the organizing principle. Development is not a...
- 9 July 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1916518
Open AccessEditorial: Decoding the spectrum of plasma cell heterogeneity: insights into maturity and longevity
A foundational question underlying this collection is how a newly minted, SL ASC in peripheral blood becomes a LLPC in the BM [3; 6; 7]. Two articles address this trajectory directly and a third provides critical ecological context.Koike and Ise offer a conceptual map of the journey, highlighting the anatomical segregation between induction sites, i.e., secondary lymphoid organs (SLO), where ASC are first generated, and effector sites, where LLPC reside. The review summaries recent advances in identifying LLPC precursors among newly generated ASC in SLO and traces the molecular programs governing their subsequent migration and maturation within the BM. Both cell-intrinsic programs and extrinsic niche signals emerge as indispensable: longevity is not an intrinsic property present at ASC birth, but progressively acquired as the cells adapt into supportive microenvironments.That maturation process has a measurable functional correlate. Nguyen et al. report experimental evidence antibody secretion is not static across the ASC lifespan. Using bulk and single-cell cultures in an in vitro BM mimetic survival system, the authors show mature BM ASC produce more IgG per cell than early-minted blood counterparts. Critically, blood ASC cultured in supportive conditions increase secretion rates overtime and acquire LLPC-like phenotypes, establishing functional output is coupled to maturational stage. This work provides a quantitative dimension to the developmental arc described by Koike and Ise, anchoring the PC biology in humans.How much room exists in the BM for this maturation to occur at scale? Tonouchi et al. tackle this question with an elegant pulse-labeling strategy in mice. Their findings demonstrate active gutassociated germinal centers (GC) continuously seed the BM with new PC, with GC-derived PC accumulating to represent ~1/3 BM PC examined at 70-80 days. The findings suggest the BM PC compartment remains dynamic with continuous inputs from ongoing immune responses, appertaining to vaccine durability and competitive niche occupancy.If the developmental arc explains the temporal dimension of PC diversity, the heterogeneity axis captures its depth. Multiple articles examine why PC with similar origins can behave differently (beyond age and location).Reinke et al. provide a molecular account of LLPC survival, focusing on the receptor-signaling networks, particularly TACI and CD28, that support LLPC to engage survival signals and upregulate anti-apoptotic machinery. The review highlights how LLPC differ from SL ASC: by a constellation of cell-intrinsic programs unlocked by the BM microenvironment. While the question of why some PC access this longevity program and others do not remains incompletely answered, this review sharpens the molecular lexicon for pursuing it.Akessé and Bonaud broaden the conceptual frame by cataloguing the multiple axes along which PC diversity is shaped. B cell precursor identity, antigen affinity, BCR signaling strength, Ig isotype, microenvironments, cytokines, cellular interactions, and temporal variables -including age, sex, and inflammatory status -all contribute to PC fate. The authors introduce the concept of "Moment" to capture how these temporal and contextual variables modulate PC differentiation throughout maturation, arguing for a model in which heterogeneity is an adaptive feature of the humoral responses. This framework complements the mechanistic detail in Reinke et al. by offering a higherorder view of the landscape.The methodological foundations for studying PC heterogeneity are addressed by Pioli and Pioli, who survey the contribution of genetically modified mouse models to the field. From early transgenic reporters marking PC identity to modern timestamping approaches allowing tracking of PC origins and lineage trajectories, the review maps the technical infrastructure for biological discoveries. This perspective piece underscores advances in understanding PC heterogeneity have been coupled to the availability of refined mouse models and points forward to where next-generation tools may take the field.PC do not exist in isolation: their survival, identity, and functions are shaped by the tissues they reside [8]. Multiple contributions examine this spatial dimension.The niche perspective offered by Tonouchi et al. is complemented by two reviews that expand its geographical frame. Wang et al. summarize the biology governing the circulating PC (CPC) pool, a small but diagnostically significant fraction of PC persistent in peripheral blood. Beyond a role as proxies for immune activation, CPC are emerging as biomarkers across infections, autoimmune diseases, and PC malignancies, with recent guidelines recognizing elevated CPC as an adverse prognostic feature in multiple myeloma. This article bridges PC biology to liquid biopsy approaches that reshape disease monitoring.Merder and Moseman extend the tissue map further. The authors examine PC that accumulate within the central nervous system (CNS) and its border zones (meninges, olfactory mucosa, and brain parenchyma). Traditionally viewed as sites poorly accessible to humoral immunity, the CNS and its borders are increasingly recognized as locations where PC function in both defense and pathology. The review recaps how local PC differentiation, migration, and persistence in the CNS contribute to neuroinvasive infection responses, CNS-targeting autoimmunity, and tumor immunology. It suggests the parallels with LLPC biology in the BM: specialized niches support local PC persistence across multiple tissues, inquiring whether general principles of niche-driven longevity operate throughout the body.The translational implications of this field run in two directions: exploiting PC biology for vaccine design and understanding its dysregulation in disease. Together, these 10 articles sketch a unified picture of PC biology where heterogeneity serves as the organizing principle. Development is not a...
- Open Access
- 5 August 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (8) , 116123
CD138 and APRIL regulate plasma cell survival, competition, and retention in the bone marrow niche
- 5 August 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (8) , 116123
Open AccessCD138 and APRIL regulate plasma cell survival, competition, and retention in the bone marrow niche
- 12 March 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (6)
Leukemogenic Kras mutation reprograms multipotent progenitors to facilitate its spread through the hematopoietic system
Leukemia-driving mutations are thought to arise in hematopoietic stem cells (HSC), yet the natural history of their spread is poorly understood. We genetically induced mutations within endogenous murine HSC and traced them in unmanipulated animals. In contrast to mutations associated with clonal hematopoiesis (such as Tet2 deletion), the leukemogenic KrasG12D mutation dramatically accelerated HSC contribution to all hematopoietic lineages. The acceleration was mediated by KrasG12D-expressing multipotent progenitors (MPP) that lacked self-renewal but showed increased proliferation and aberrant transcriptome. The deletion of osteopontin, a secreted negative regulator of stem/progenitor cells, delayed the early expansion of mutant progenitors. KrasG12D-carrying cells showed increased CXCR4-driven motility in the bone marrow, and the blockade of CXCR4 reduced the expansion of MPP in vivo. Finally, therapeutic blockade of KRASG12D spared mutant HSC but reduced the expansion of mutant MPP and their mature progeny. Thus, transforming mutations facilitate their own spread from stem cells by reprogramming MPP, creating a preleukemic state via a two-component stem/progenitor circuit.
- 12 March 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (6)
Leukemogenic Kras mutation reprograms multipotent progenitors to facilitate its spread through the hematopoietic system
Leukemia-driving mutations are thought to arise in hematopoietic stem cells (HSC), yet the natural history of their spread is poorly understood. We genetically induced mutations within endogenous murine HSC and traced them in unmanipulated animals. In contrast to mutations associated with clonal hematopoiesis (such as Tet2 deletion), the leukemogenic KrasG12D mutation dramatically accelerated HSC contribution to all hematopoietic lineages. The acceleration was mediated by KrasG12D-expressing multipotent progenitors (MPP) that lacked self-renewal but showed increased proliferation and aberrant transcriptome. The deletion of osteopontin, a secreted negative regulator of stem/progenitor cells, delayed the early expansion of mutant progenitors. KrasG12D-carrying cells showed increased CXCR4-driven motility in the bone marrow, and the blockade of CXCR4 reduced the expansion of MPP in vivo. Finally, therapeutic blockade of KRASG12D spared mutant HSC but reduced the expansion of mutant MPP and their mature progeny. Thus, transforming mutations facilitate their own spread from stem cells by reprogramming MPP, creating a preleukemic state via a two-component stem/progenitor circuit.
- Open Access
- 18 June 2024
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 12
Fine-tuning spatial-temporal dynamics and surface receptor expression support plasma cell-intrinsic longevity
Durable serological memory following vaccination is critically dependent on the production and survival of long-lived plasma cells (LLPCs). Yet, the factors that control LLPC specification and survival remain poorly resolved. Using intravital two-photon imaging, we find that in contrast to most plasma cells (PCs) in the bone marrow (BM), LLPCs are uniquely sessile and organized into clusters that are dependent on APRIL, an important survival factor. Using deep, bulk RNA sequencing, and surface protein flow-based phenotyping, we find that LLPCs express a unique transcriptome and phenotype compared to bulk PCs, fine-tuning expression of key cell surface molecules, CD93, CD81, CXCR4, CD326, CD44, and CD48, important for adhesion and homing. Conditional deletion of Cxcr4 in PCs following immunization leads to rapid mobilization from the BM, reduced survival of antigen-specific PCs, and ultimately accelerated decay of antibody titer. In naïve mice, the endogenous LLPCs BCR repertoire exhibits reduced diversity, reduced somatic mutations, and increased public clones and IgM isotypes, particularly in young mice, suggesting LLPC specification is non-random. As mice age, the BM PC compartment becomes enriched in LLPCs, which may outcompete and limit entry of new PCs into the LLPC niche and pool.
- 18 June 2024
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 12
Open AccessFine-tuning spatial-temporal dynamics and surface receptor expression support plasma cell-intrinsic longevity
Durable serological memory following vaccination is critically dependent on the production and survival of long-lived plasma cells (LLPCs). Yet, the factors that control LLPC specification and survival remain poorly resolved. Using intravital two-photon imaging, we find that in contrast to most plasma cells (PCs) in the bone marrow (BM), LLPCs are uniquely sessile and organized into clusters that are dependent on APRIL, an important survival factor. Using deep, bulk RNA sequencing, and surface protein flow-based phenotyping, we find that LLPCs express a unique transcriptome and phenotype compared to bulk PCs, fine-tuning expression of key cell surface molecules, CD93, CD81, CXCR4, CD326, CD44, and CD48, important for adhesion and homing. Conditional deletion of Cxcr4 in PCs following immunization leads to rapid mobilization from the BM, reduced survival of antigen-specific PCs, and ultimately accelerated decay of antibody titer. In naïve mice, the endogenous LLPCs BCR repertoire exhibits reduced diversity, reduced somatic mutations, and increased public clones and IgM isotypes, particularly in young mice, suggesting LLPC specification is non-random. As mice age, the BM PC compartment becomes enriched in LLPCs, which may outcompete and limit entry of new PCs into the LLPC niche and pool.
- Open Access
- 6 June 2024
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 12
Fine-tuning spatial-temporal dynamics and surface receptor expression support plasma cell-intrinsic longevity
Durable serological memory following vaccination is critically dependent on the production and survival of long-lived plasma cells (LLPCs). Yet, the factors that control LLPC specification and survival remain poorly resolved. Using intra-vital two-photon imaging, we find that in contrast to most plasma cells in the bone marrow (BM), LLPCs are uniquely sessile and organized into clusters that are dependent on APRIL, an important survival factor. Using deep, bulk RNA sequencing, and surface protein flow-based phenotyping, we find that LLPCs express a unique transcriptome and phenotype compared to bulk PCs, fine tuning expression of key cell surface molecules, CD93, CD81, CXCR4, CD326, CD44 and CD48, important for adhesion and homing. Conditional deletion of Cxcr4 in PCs following immunization leads to rapid mobilization from the BM, reduced survival of antigen-specific PCs, and ultimately accelerated decay of antibody titer. In naïve mice, the endogenous LLPCs BCR repertoire exhibits reduced diversity, reduced somatic mutations, and increased public clones and IgM isotypes, particularly in young mice, suggesting LLPC specification is non-random. As mice age, the BM PC compartment becomes enriched in LLPCs, which may outcompete and limit entry of new PCs into the LLPC niche and pool.
- 6 June 2024
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 12
Open AccessFine-tuning spatial-temporal dynamics and surface receptor expression support plasma cell-intrinsic longevity
Durable serological memory following vaccination is critically dependent on the production and survival of long-lived plasma cells (LLPCs). Yet, the factors that control LLPC specification and survival remain poorly resolved. Using intra-vital two-photon imaging, we find that in contrast to most plasma cells in the bone marrow (BM), LLPCs are uniquely sessile and organized into clusters that are dependent on APRIL, an important survival factor. Using deep, bulk RNA sequencing, and surface protein flow-based phenotyping, we find that LLPCs express a unique transcriptome and phenotype compared to bulk PCs, fine tuning expression of key cell surface molecules, CD93, CD81, CXCR4, CD326, CD44 and CD48, important for adhesion and homing. Conditional deletion of Cxcr4 in PCs following immunization leads to rapid mobilization from the BM, reduced survival of antigen-specific PCs, and ultimately accelerated decay of antibody titer. In naïve mice, the endogenous LLPCs BCR repertoire exhibits reduced diversity, reduced somatic mutations, and increased public clones and IgM isotypes, particularly in young mice, suggesting LLPC specification is non-random. As mice age, the BM PC compartment becomes enriched in LLPCs, which may outcompete and limit entry of new PCs into the LLPC niche and pool.
- 8 February 2024
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 24 (7) , 461-470
New insights into the ontogeny, diversity, maturation and survival of long-lived plasma cells
Plasma cells are unique immune effectors, capable of producing large amounts of high-affinity antibodies that protect against pathogenic infections. Although most plasma cells have short lifespans, certain conditions or vaccinations can give rise to long-lived plasma cells (LLPCs) that provide individuals with lifelong protection against pathogen exposure. The nature of these LLPCs is poorly understood; however, recent studies have shed new light on the ontogeny, diversity, maturation and survival of these unique cells. Whereas LLPCs had been thought to arise preferentially from germinal centres, novel genetic tools have revealed that they can originate from various stages throughout the humoral response. Furthermore, new single-cell analyses have shown that mouse and human plasma cells are heterogeneous and may undergo further maturation in situ in the bone marrow niche. Finally, plasma cells were previously considered to be sessile cells maintained in fixed survival niches, but new data show that plasma cell subsets can differentially migrate and organize into clusters that may be associated with survival niches. These descriptive findings provide new insights into how cell-intrinsic programmes and extrinsic factors may regulate the longevity of plasma cells in various contexts, which suggest new research avenues for their functional validation.
- 8 February 2024
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 24 (7) , 461-470
New insights into the ontogeny, diversity, maturation and survival of long-lived plasma cells
Plasma cells are unique immune effectors, capable of producing large amounts of high-affinity antibodies that protect against pathogenic infections. Although most plasma cells have short lifespans, certain conditions or vaccinations can give rise to long-lived plasma cells (LLPCs) that provide individuals with lifelong protection against pathogen exposure. The nature of these LLPCs is poorly understood; however, recent studies have shed new light on the ontogeny, diversity, maturation and survival of these unique cells. Whereas LLPCs had been thought to arise preferentially from germinal centres, novel genetic tools have revealed that they can originate from various stages throughout the humoral response. Furthermore, new single-cell analyses have shown that mouse and human plasma cells are heterogeneous and may undergo further maturation in situ in the bone marrow niche. Finally, plasma cells were previously considered to be sessile cells maintained in fixed survival niches, but new data show that plasma cell subsets can differentially migrate and organize into clusters that may be associated with survival niches. These descriptive findings provide new insights into how cell-intrinsic programmes and extrinsic factors may regulate the longevity of plasma cells in various contexts, which suggest new research avenues for their functional validation.
- Open Access
Fine-tuning spatial-temporal dynamics and surface receptor expression support plasma cell-intrinsic longevity
Durable serological memory following vaccination is critically dependent on the production and survival of long-lived plasma cells (LLPCs). Yet, the factors that control LLPC specification and survival remain poorly resolved. Using intra-vital two-photon imaging, we find that in contrast to most plasma cells in the bone marrow (BM), LLPCs are uniquely sessile and organized into clusters that are dependent on APRIL, an important survival factor. Using deep, bulk RNA sequencing, and surface protein flow-based phenotyping, we find that LLPCs express a unique transcriptome and phenotype compared to bulk PCs, fine tuning expression of key cell surface molecules, CD93, CD81, CXCR4, CD326, CD44 and CD48, important for adhesion and homing. Conditional deletion of Cxcr4 in PCs following immunization leads to rapid mobilization from the BM, reduced survival of antigen-specific PCs, and ultimately accelerated decay of antibody titer. In naïve mice, the endogenous LLPCs BCR repertoire exhibits reduced diversity, reduced somatic mutations, and increased public clones and IgM isotypes, particularly in young mice, suggesting LLPC specification is non-random. As mice age, the BM PC compartment becomes enriched in LLPCs, which may outcompete and limit entry of new PCs into the LLPC niche and pool. HIGHLIGHTS: LLPCs have reduced motility and increased clustering in the BM LLPCs accumulate in the BM PC pool, with mouse age LLPCs have unique surfaceome, transcriptome, and BCR clonality CXCR4 controls maintenance of PCs and antibody titers
Open AccessFine-tuning spatial-temporal dynamics and surface receptor expression support plasma cell-intrinsic longevity
Durable serological memory following vaccination is critically dependent on the production and survival of long-lived plasma cells (LLPCs). Yet, the factors that control LLPC specification and survival remain poorly resolved. Using intra-vital two-photon imaging, we find that in contrast to most plasma cells in the bone marrow (BM), LLPCs are uniquely sessile and organized into clusters that are dependent on APRIL, an important survival factor. Using deep, bulk RNA sequencing, and surface protein flow-based phenotyping, we find that LLPCs express a unique transcriptome and phenotype compared to bulk PCs, fine tuning expression of key cell surface molecules, CD93, CD81, CXCR4, CD326, CD44 and CD48, important for adhesion and homing. Conditional deletion of Cxcr4 in PCs following immunization leads to rapid mobilization from the BM, reduced survival of antigen-specific PCs, and ultimately accelerated decay of antibody titer. In naïve mice, the endogenous LLPCs BCR repertoire exhibits reduced diversity, reduced somatic mutations, and increased public clones and IgM isotypes, particularly in young mice, suggesting LLPC specification is non-random. As mice age, the BM PC compartment becomes enriched in LLPCs, which may outcompete and limit entry of new PCs into the LLPC niche and pool. HIGHLIGHTS: LLPCs have reduced motility and increased clustering in the BM LLPCs accumulate in the BM PC pool, with mouse age LLPCs have unique surfaceome, transcriptome, and BCR clonality CXCR4 controls maintenance of PCs and antibody titers
- Open Access
- 11 January 2023
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 210 (5) , 595-608
TNF-α Limits Serological Memory by Disrupting the Bone Marrow Niche
Both infection and autoimmune disease can disrupt pre-existing Ab titers leading to diminished serological memory, yet the underlying mechanisms are not well understood. In this article, we report that TNF-α, an inflammatory cytokine, is a master regulator of the plasma cell (PC) niche in the bone marrow (BM). Acute rTNF-α treatment depletes previously existing Ab titers after vaccination by limiting PC occupancy or retention in the BM. Consistent with this phenomenon, mice lacking TNF-α signaling have elevated PC capacity in the BM and higher Ab titers. Using BM chimeric mice, we found that PC egress from the BM is regulated in a cell-extrinsic manner, by radiation-resistant cells via TNF-α receptor 1 signaling, leading to increased vascular permeability and CD138 downregulation on PCs. PC motility and egress in the BM are triggered within 6 h of recombinant TNF-α treatment. In addition to promoting egress, TNF-α signaling also prevented re-engraftment into the BM, leading to reduced PC survival. Although other inflammatory stimuli can promote PC egress, TNF-α signaling is necessary for limiting the PC capacity in the BM. Collectively, these data characterize how TNF-α–mediated inflammation attenuates the durability of serological memory and shapes the overall size and composition of the Ab-secreting cell pool in the BM.
- 11 January 2023
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 210 (5) , 595-608
Open AccessTNF-α Limits Serological Memory by Disrupting the Bone Marrow Niche
Both infection and autoimmune disease can disrupt pre-existing Ab titers leading to diminished serological memory, yet the underlying mechanisms are not well understood. In this article, we report that TNF-α, an inflammatory cytokine, is a master regulator of the plasma cell (PC) niche in the bone marrow (BM). Acute rTNF-α treatment depletes previously existing Ab titers after vaccination by limiting PC occupancy or retention in the BM. Consistent with this phenomenon, mice lacking TNF-α signaling have elevated PC capacity in the BM and higher Ab titers. Using BM chimeric mice, we found that PC egress from the BM is regulated in a cell-extrinsic manner, by radiation-resistant cells via TNF-α receptor 1 signaling, leading to increased vascular permeability and CD138 downregulation on PCs. PC motility and egress in the BM are triggered within 6 h of recombinant TNF-α treatment. In addition to promoting egress, TNF-α signaling also prevented re-engraftment into the BM, leading to reduced PC survival. Although other inflammatory stimuli can promote PC egress, TNF-α signaling is necessary for limiting the PC capacity in the BM. Collectively, these data characterize how TNF-α–mediated inflammation attenuates the durability of serological memory and shapes the overall size and composition of the Ab-secreting cell pool in the BM.
- Open Access
- 24 October 2022
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 11
CD169+ macrophages orchestrate plasmacytoid dendritic cell arrest and retention for optimal priming in the bone marrow of malaria-infected mice
Plasmacytoid dendritic cells (pDCs) are the most potent producer of type I interferon (IFN), but how pDC is primed in vivo is poorly defined. Using a mouse model of severe malaria, we have previously established that upon priming by CD169+ macrophages (MPs), pDC initiates type I IFN-I secretion in the bone marrow (BM) of infected mice via cell-intrinsic TLR7 sensing and cell-extrinsic STING sensing. Herein we show that CD169+ MP and TLR7 sensing are both required for pDC arrest during priming, suggesting CD169+ MP are the source of TLR7 ligands. We establish that TLR7 sensing in pDC and chemotaxis are both required for pDC arrest and functional communication with CD169+ MP in the BM. Lastly, we demonstrate that STING sensing in CD169+ MP control pDC initiation of type I IFN production while also regulating pDC clustering and retention/egress from the BM. Collectively, these results link pDC acquisition of type I IFN-secreting capacity with changes in their motility, homing and interactions with CD169+ MP during infection. Thus, targeting this cellular interaction may help modulate type I IFN to improve outcomes of microbial infections and autoimmune diseases.
- 24 October 2022
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 11
Open AccessCD169+ macrophages orchestrate plasmacytoid dendritic cell arrest and retention for optimal priming in the bone marrow of malaria-infected mice
Plasmacytoid dendritic cells (pDCs) are the most potent producer of type I interferon (IFN), but how pDC is primed in vivo is poorly defined. Using a mouse model of severe malaria, we have previously established that upon priming by CD169+ macrophages (MPs), pDC initiates type I IFN-I secretion in the bone marrow (BM) of infected mice via cell-intrinsic TLR7 sensing and cell-extrinsic STING sensing. Herein we show that CD169+ MP and TLR7 sensing are both required for pDC arrest during priming, suggesting CD169+ MP are the source of TLR7 ligands. We establish that TLR7 sensing in pDC and chemotaxis are both required for pDC arrest and functional communication with CD169+ MP in the BM. Lastly, we demonstrate that STING sensing in CD169+ MP control pDC initiation of type I IFN production while also regulating pDC clustering and retention/egress from the BM. Collectively, these results link pDC acquisition of type I IFN-secreting capacity with changes in their motility, homing and interactions with CD169+ MP during infection. Thus, targeting this cellular interaction may help modulate type I IFN to improve outcomes of microbial infections and autoimmune diseases.